Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

26 Nov 2019 Evaluate

With reference to 'Alembic Pharmaceuticals receives USFDA Final Approval for Silodosin Capsules, 4 mg and 8 mg', Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Silodosin Capsules, 4 mg and 8 mg. the company has submitted its press release. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..